Decreased immunoglobulin production in
and controls.
Monocyte functions were normal when tested by addition of indomethacin or 2-mercaptoethanol to the mitogen activated cultures.
The defect in mitogen stimulated immunoglobulin production in vitro of RA mononuclear cells thus was more pronounced with time and probably reflects impaired mediator associated help in the differentiation of B lymphocytes into immunoglobulin secreting cells.
There is ample evidence of aberrant immunofunctions in rheumatoid arthritis (RA), including serum hyperimmunoglobulinaemia and production of autoantibodies.' The mechanisms leading to these abnormalities are still obscure. In vitro culture studies with blood lymphocytes have shown, paradoxically, a decreased mitogen stimulated immunoglobulin secretion.2 The reasons for decreased immunoglobulin synthesis are unknown. It is also unknown whether these cellular mechanisms are related to B cells, T cells, or monocytes. We have extended these studies and report that this phenomenon becomes more pronounced during six months' follow up of recent onset disease. In this study we also report on experiments designed to determine whether the decreased immunoglobulin production is due to changes in the functions of B cells, T helper or T suppressor cells, or monocytes.
Patients and methods

PATIENTS AND CONTROLS
The patient group comprised 58 patients (17 men Helper functions, on the other hand, seem abnormal in this study. Firstly, we found that IL-2 secretion induced by phytohaemagglutinin was significantly reduced compared with controls, in agreement with earlier studies.26 27 Increased IL-2 production in RA has also been reported, however. 28 Recently, a specific loss of this subset has been shown to occur in RA, which may be relevant.34 A weak proliferation of the true helper subset CD4+2H4-4H4+ owing to depressed IL-2 production may lead to low activation and especially poor production of differentiation factors for B cells. It should be pointed out, however, that it is unclear which cells are responsible for mediator production after concanavalin A or S aureus Cowan I stimulation.
Thus we conclude that the most probable mechanism for the defect in in vitro immunoglobulin synthesis in RA is impaired production of IL-2 and, possibly, other mediators. What then might be the cause of abnormal mediator function is another question. Our findings show that during the first six months of the disease the defect in immunoglobulin synthesis becomes more pronounced, which suggests an association with the progress of the disease or, alternatively, with the drug treatment. At the onset of the study the patients did not receive any second line antirheumatic drugs but, nevertheless, showed depressed immunoglobulin production. Non-steroidal anti-inflammatory drugs might have been used, however. The effect of these drugs is currently under investigation in our laboratory.
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